Researchers reveal a strategy that helps medulloblastoma, the most prevalent malignant brain tumor in children, spread and grow on the leptomeninges, the membranes surrounding the brain and spinal ...

A new study led by the University of Oxford has revealed that a common and usually harmless virus may positively influence ...

Updated data from the Phase 1b trial of IMA203 in patients with metastatic melanoma with substantially longer follow-up compared to the last presentation in October 2024, and including data from ...

Iovance Biotherapeutics (NASDAQ: IOVA) is a stock that many investors think has a lot of upside. Iovance's cash burn hasn't ...

Researchers at Baylor College of Medicine, Texas Children's Hospital, the Hospital for Sick Children in Toronto and ...

Study findings show that the standardized 6-month surveillance protocols for all patients with low-risk uveal melanoma may be ...

Researchers have developed an innovative nano-immune agonist that significantly improves immunotherapy outcomes for ...

A new study finds that fragments of tumor DNA in a patient's bloodstream could show that they are at high risk of a melanoma ...

A new implant safely triggers potent immune responses against hard-to-treat cancers showing "promise" for pancreatic and ...

Metastatic castration-resistant prostate cancer (mCRPC) treatment can involves chemotherapy, radiation, and more. Find the latest options here.

Recurrence-free survival rates were similar, even when patients quit adjuvant immunotherapy early, according to a new report.